miR-375 maintains normal pancreatic α- and β-cell mass
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 ( miR-375 ), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 ( 375KO ) are hyperglycemic, exhibit increased total pancreatic α-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic β-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice ( ob / ob ), a model of increased β-cell mass, exhibit increased expression of miR-375 . Genetic deletion of miR-375 from these animals ( 375 / ob ) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, α- and β-cell turnover, and adaptive β-cell expansion in response to increasing insulin demand in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“knockout of miR-375 promotes progressive hyperglycemia in mouse models due to decreased insulin content and progressive loss of β-cell mass ( 32 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mir-375 is also involved in adaptive β-cell expansion in response to insulin resistance (518).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [518]
In the citing paper
“miR-375 also regulates many genes involved in cellular proliferation, which likely underlies its effect on the maintenance of beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
In the citing paper
“miR-375, an islet-specific microRNA that regulates both insulin secretion and beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · cited 1×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundMethodSelf-citationA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 6×
“Northern blotting, Western blotting, and luciferase assays were performed as previously described (13).”
BackgroundMethodResultInfluentialSelf-citationControl of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundThe Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundRegulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 301–400 of 767
Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes
Citro, A., Neroni, A., Pignatelli, C., Campo, F., Policardi, M., Monieri, M., Pellegrini, S., Dugnani, E., Manenti, F., Maffia, M. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36582-1 · Cited by 45
Implications of microRNAs in the pathogenesis of diabetes
Park, S., Jeong, H.-J., Yang, W., & Lee, W. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0017-6 · Cited by 44
“Genetic deletion of miR-375 in obese mice led to a profound loss of b-cells and premature death (Poy et al. 2009).”
BackgroundInfluentialHu, A., Huang, J., Xu, W., Jin, X., Li, J., Tang, Y., Huang, X., Cui, H.-J., Sun, G., Li, R., et al. (2015) · Europe PMC (PubMed Central) · Cited by 45
Bacon, S., Engelbrecht, B., Schmid, J., Pfeiffer, S., Gallagher, R., McCarthy, A., Burke, M., Concannon, C. G., Prehn, J. H. M., & Byrne, M. M. (2015) · Genes · doi:10.3390/genes6020399 · Cited by 48
Kinoshita, T., Hanazawa, T., Nohata, N., Okamoto, Y., & Seki, N. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.75 · Cited by 45
Downregulation of miR‐375 in aldosterone‐producing adenomas promotes tumour cell growth via MTDH
He, J., Cao, Y., Su, T., Jiang, Y., Jiang, L., Zhou, W., Zhang, C., Wang, W., & Ning, G. (2015) · Clinical Endocrinology · doi:10.1111/cen.12814 · Cited by 42
Insights into the potential use of microRNAs as biomarker in cancer
Anindo, M. I. K., & Yaqinuddin, A. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.08.006 · Cited by 40
Pancreatic islet differentiation of human embryonic stem cells by microRNA overexpression
Lahmy, R., Soleimani, M., Sanati, M. H., Behmanesh, M., Kouhkan, F., & Mobarra, N. (2013) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1787 · Cited by 40
“Of these, the role of miR-375 has been well-studied in zebrafish, mouse and human during pancreas development (Kloosterman et al., 2007; Joglekar et al., 2009; Poy et al., 2009).”
BackgroundAdeno-Associated Virus-Mediated MicroRNA Delivery and Therapeutics
Xie, J., Burt, D. R., & Gao, G. (2015) · Seminars in Liver Disease · doi:10.1055/s-0034-1397352 · Cited by 45
In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion
Bijkerk, R., Esguerra, J. L. S., Ellenbroek, J. H., Au, Y. W., Hanegraaf, M. A. J., de Koning, E. J. P., Eliasson, L., & van Zonneveld, A. J. (2019) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0763 · Cited by 40
Pfeiffer, S., Sánchez-Lechuga, B., Donovan, P., Halang, L., Prehn, J. H. M., Campos‐Caro, A., Byrne, M. M., & López‐Tinoco, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-57838-6 · Cited by 41
Over-expression of miR375 reduces glucose-induced insulin secretion in Nit-1 cells
Xia, H.-Q., Pan, Y., Peng, J., & Lu, G. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-9973-9 · Cited by 44
sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells
Lin, M., Shi, C., Lin, X., Pan, J., Shen, S.-F., Xu, Z., & Chen, Q. (2016) · Gene · doi:10.1016/j.gene.2016.02.001 · Cited by 39
“…are involved in cell growth, development, differentiation, stress, and apoptosis, such as miR-1 in cardiac development (Duan et al., 2014), miR-143 in adipocyte differentiation (Chen et al., 2014), miR-375 in mammalian pancreatic cell development and the secretion of insulin (Poy et al., 2009).”
BackgroundA Review of micro RNAs changes in T2DM in animals and humans
Afsharmanesh, M. R., Mohammadi, Z., Mansourian, A. R., & Jafari, S. M. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13431 · Cited by 40
“Poy et al showed that about 10% of the total miRNA in pancreatic cells belonged to miR375.(21) This miRNA is required to regulate genes involved in normal β-cells mass maintenance, insulin secretion, and glucose homeostasis.”
BackgroundMicroRNA-17-92 cluster regulates pancreatic beta-cell proliferation and adaptation
Chen, Y., Tian, L., Wan, S., Xie, Y., Chen, X., Xiao, J., Zhao, Q., Wang, C., Zhang, K., Hock, J. M., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.037 · Cited by 39
Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?
Beck, R., Stýblo, M., & Sethupathy, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0845-8 · Cited by 45
López‐Beas, J., Capilla‐González, V., Aguilera, Y., Mellado-Damas, N., Lachaud, C. C., Martín, F., Smani, T., Soria, B., & Hmadcha, A. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.06.002 · Cited by 44
A Simple Matter of Life and Death—The Trials of Postnatal Beta-Cell Mass Regulation
Tarabra, E., Pelengaris, S., & Khan, M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/516718 · Cited by 40
“Therefore, it is becoming clear that miR-375 targets a suit of genes that negatively regulate cell growth and proliferation and that aberrant loss of this miRNA leads to dramatic reduction of beta-cell mass [15].”
BackgroundKwon, D., Chang, B., & Kim, J. (2014) · BioMed Research International · doi:10.1155/2014/236385 · Cited by 39
Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs
Capuani, B., Pacifici, F., Della‐Morte, D., & Lauro, D. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00719 · Cited by 40
Bang‐Berthelsen, C. H., Pedersen, L., Fløyel, T., Hagedorn, P., Gylvin, T., & Pociot, F. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-97 · Cited by 39
Novotny, G. W., Lundh, M., Backe, M. B., Christensen, D. P., Hansen, J. B., Dahllöf, M. S., Pallesen, E. M. H., & Mandrup-Poulsen, T. R. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.09.014 · Cited by 41
Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1
Wang, S., Ai, H., Liu, L., Zhang, X., Gao, F., Zheng, L., Yi, J., Sun, L., Yu, C., Zhao, H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00190.2019 · Cited by 37
MicroRNAs can effectively induce formation of insulin-producing cells from mesenchymal stem cells
Bai, C., Gao, Y., Li, X., Wang, K., Xiong, H., Shan, Z., Zhang, P., Wang, W., Guan, W., & Ma, Y. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2259 · Cited by 37
Glucolipotoxicity-Inhibited miR-299-5p Regulates Pancreatic β-Cell Function and Survival
Huang, Q., You, W., Li, Y., Sun, Y., Zhou, Y., Zhang, Y., Liu, D., Zhan, S., Zhu, Y., & Han, X. (2018) · Diabetes · doi:10.2337/db18-0223 · Cited by 40
The myriad essential roles of microRNAs in cardiovascular homeostasis and disease
Neppl, R. L., & Wang, D. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.06.003 · Cited by 36
“Importantly, miR-375 null mice are hyperglycemic with elevated gluconeogenesis and hepatic glucose output.(298) Interestingly, it was discovered that these mice have reduced b-cell mass due to impaired b-cell proliferation likely due to elevated expression of cell adhesion molecule 1 (Cadm1), gephyrin (Gphn), caveolin…”
BackgroundImplication of epigenetics in pancreas development and disease
Quilichini, E., & Haumaître, C. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.10.010 · Cited by 39
Song, I., Roels, S., Martens, G. A., & Bouwens, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186480 · Cited by 39
The Role of Epigenetics in Type 1 Diabetes
Xie, Z., Chang, C., Huang, G., & Zhou, Z. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3449-2_9 · Cited by 41
Pillai, S. S., Lakhani, H. V., Zehra, M., Wang, J., Dilip, A., Puri, N., O'Hanlon, K. M., & Sodhi, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186698 · Cited by 36
Kasai, H., Hatakeyama, H., Ohno, M., & Takahashi, N. K. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_14 · Cited by 45
Yan, D., Song, Y., Zhang, B., Cao, G., Zhou, H., Li, H., Sun, H., Deng, M., Qiu, Y., Yi, W., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03620-0 · Cited by 36
Hinton, A. C., Hunter, S. E., Afrikanova, I., Jones, G. A., Lopez, A. D., Fogel, G. B., Hayek, A., & King, C. C. (2014) · Stem Cells · doi:10.1002/stem.1739 · Cited by 42
Suksangrat, T., Phannasil, P., & Jitrapakdee, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_7 · Cited by 38
Vezza, T., Marañón, A., Canet, F., Díaz-Pozo, P., Marti, M., D’Ocón, P., Apostolova, N., Rocha, M., & Víctor, V. M. (2021) · Antioxidants · doi:10.3390/antiox10050802 · Cited by 38
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis
Wendt, A., & Eliasson, L. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102199 · Cited by 37
Taylor, H. J., Hung, Y.-H., Narisu, N., Erdos, M. R., Kanke, M., Yan, T., Grenko, C. M., Swift, A. J., Bonnycastle, L. L., Sethupathy, P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206797120 · Cited by 36
Othman, M. S., Hafez, M. M., & Moneim, A. E. A. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-02012-x · Cited by 38
RetractedWei, R., Yang, J., Hou, W., Liu, G., Gao, M., Zhang, L., Wang, H., Mao, G., Gao, H., Chen, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072513 · Cited by 34
Chen, J., Zhang, X., Wang, Y., Ye, Y., & Huang, Z. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22531 · Cited by 34
RNA binding protein HuD contributes to β-cell dysfunction by impairing mitochondria dynamics
Hong, Y., Tak, H., Kim, C., Kang, H., Ji, E., Ahn, S., Jung, M., Kim, H. L., Lee, J. H., Kim, W., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0447-x · Cited by 35
Bioactive Functions of Milk Proteins: a Comparative Genomics Approach
Sharp, J. A., Modepalli, V., Enjapoori, A. K., Bisana, S., Abud, H. E., Lefèvre, C. M., & Nicholas, K. R. (2014) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9331-6 · Cited by 41
Towards microRNA-based therapeutics for diabetic nephropathy
Alvarez, M. L., & DiStefano, J. K. (2012) · Diabetologia · doi:10.1007/s00125-012-2768-x · Cited by 36
MicroRNAs in mouse development and disease
Lewis, M. A., & Steel, K. P. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.02.004 · Cited by 36
Perillo, M., Wang, Y. J., Leach, S. D., & Arnone, M. I. (2016) · BMC Evolutionary Biology · doi:10.1186/s12862-016-0686-0 · Cited by 36
Post-transcriptional regulation in metabolic diseases
Kim, W., & Lee, E. K. (2012) · RNA Biology · doi:10.4161/rna.20091 · Cited by 36
Altered Retinal MicroRNA Expression Profiles in Early Diabetic Retinopathy: AnIn SilicoAnalysis
Xiong, F., Du, X., Hu, J., Li, T., Du, S., & Wu, Q. E. (2014) · Current Eye Research · doi:10.3109/02713683.2013.872280 · Cited by 35
“In addition, miR-375, which is highly expressed in pancreatic islets, is required for normal glucose homeostasis and regulates a cluster of genes that control cellular growth and proliferation.(26) In our study, miR-375 was down-regulated in DM retinas.”
BackgroundDeng, J., & Guo, F. (2019) · ExRNA · doi:10.1186/s41544-019-0038-5 · Cited by 35
“Omics” and “epi-omics” underlying the β-cell adaptation to insulin resistance
Jesus, D. F. D., & Kulkarni, R. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.003 · Cited by 36
“miR-375 is highly expressed in rodent models of islet hyperplasia and mice lacking miR-375 in b-cells present impaired b-cell proliferation and decreased b-cell mass demonstrating the importance of microRNAs in controlling b-cell function and survival [55].”
BackgroundEpigenetic Regulation of β Cell Identity and Dysfunction
Sun, X., Wang, L., Obayomi, S. M. B., & Wei, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.725131 · Cited by 33
“miR-375 knockout mice showed reduced b cell mass, together with an increase in plasma glucagon and gluconeogenesis, suggesting that miR-375 levels are essential for glucose homeostasis and proliferation of b-cells (83), though its direct effect on b cell remains to be determined.”
BackgroundTargeting miR-375 in gastric cancer
Xu, Y., Deng, Y., Yan, X., & Zhou, T. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.581232 · Cited by 35
MicroRNAs: New Insights into Chronic Childhood Diseases
Omran, A. G., Elimam, D., & Yin, F. (2013) · BioMed Research International · doi:10.1155/2013/291826 · Cited by 36
MicroRNA single‐nucleotide polymorphisms and diabetes mellitus: A comprehensive review
Zhang, Y., Bai, R., Liu, C., Ma, C., Chen, X., Yang, J., & Sun, D. (2018) · Clinical Genetics · doi:10.1111/cge.13491 · Cited by 33
Gao, Y., Zhang, R., Dai, S., Zhang, X., Li, X., & Bai, C. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00351 · Cited by 37
“Furthermore, miR375 can also directly induce the differentiation of pancreatic beta cells from induced pluripotent stem cells (Poy et al., 2009; Bai et al., 2017a), however, the mechanism underlying this process remains unclear (Lahmy et al., 2014).”
BackgroundGuo, J., Zhao, W. H., Zhan, S., Li, L., Zhong, T., Wang, L., Dong, Y., & Zhang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165764 · Cited by 36
Rodil-García, P., Arellanes-Licea, E. D. C., Montoya-Contreras, A., & Salazar‐Olivo, L. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122552 · Cited by 32
“We also analyzed the expression of miR-375 in neonates with differential birth weights since this miRNA participates in pancreatic islet development and adipogenesis in vitro, its expression could be regulated by glucose and is currently a potential target for T2D treatment [13,14,26,27].”
BackgroundExtracellular miRNAs in redox signaling: Health, disease and potential therapies
Ruiz, G. P., Camara, H., Fazolini, N. P. B., & Mori, M. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.004 · Cited by 31
Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications
Sufianov, A. A., Kostin, A. A., Begliarzade, S., Kudriashov, V., Ilyasova, T., Liang, Y., Mukhamedzyanov, A., & Beylerli, O. (2023) · Non-coding RNA Research · doi:10.1016/j.ncrna.2023.02.001 · Cited by 34
Using stem cells to produce insulin
Soria, B., Gauthier, B. R., Martín, F., Tejedo, J. R., Bedoya, F. J., Rojas, A., & Hmadcha, A. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1066330 · Cited by 31
Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance
Galimov, A., Hartung, A., Trepp, R., Mader, A., Flück, M., Linke, A., Blüher, M., Christ, E., & Krützfeldt, J. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1322-y · Cited by 32
Mirra, P., Raciti, G. A., Nigro, C., Fiory, F., D’Esposito, V., Formisano, P., Bèguinot, F., & Miele, C. (2015) · Epigenomics · doi:10.2217/epi.15.18 · Cited by 31
Retinal expression of small non-coding RNAs in a murine model of proliferative retinopathy
Liu, C., Wang, Z., Sun, Y., SanGiovanni, J. P., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep33947 · Cited by 32
Ribeiro, P. V. D. M., da Silva, A., de Almeida, A. P., Hermsdorff, H. H. M., & Alfenas, R. D. C. G. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1392290 · Cited by 30
Zhao, X., Shu, F., Wang, X., Wang, F., Wu, L., Li, L., & Lv, H. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.035 · Cited by 30
“T expressed in pancreatic islets, and have functional role of regulating glucose-stimulated insulin exocytosis (Poy et al., 2004, 2009).”
BackgroundRoux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients
Rega‐Kaun, G., Kaun, C., Jaegersberger, G., Prager, M., Hackl, M., Demyanets, S., Wojta, J., & Hohensinner, P. J. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04190-y · Cited by 30
β-Cell specific transcription factors in the context of diabetes mellitus and β-cell regeneration
Balakrishnan, S., Dhavamani, S., & Prahalathan, C. (2020) · Mechanisms of Development · doi:10.1016/j.mod.2020.103634 · Cited by 32
Natalicchio, A., Montagnani, M., Gallo, M., Marrano, N., Faggiano, A., Zatelli, M. C., Mazzilli, R., Argentiero, A., Danesi, R., D’Oronzo, S., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101573 · Cited by 34
“It regulates b-cell adaptation to metabolic stress and insulin resistance;(19) therefore, mice with global miR-375 knockout show progressive hyperglycemia with lower numbers of b-cells and impaired compensatory b-cell proliferation.(20,21) Similarly, miR-223 and miR-455 expression is increased in islets of diabetic an…”
BackgroundMicroRNAs and the functional β cell mass: For better or worse
Guay, C., & Regazzi, R. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.03.006 · Cited by 30
Chang, X., Li, S., Li, J., Yin, L., Zhou, T., Zhang, C., Chen, X., & Sun, K. (2014) · Journal of Diabetes Research · doi:10.1155/2014/761938 · Cited by 30
“In particular, miR-375 is selectively expressed in pancreatic islets [4, 5] and regulates insulin secretion and islet β-cell proliferation to participate in normal glucose homeostasis.”
BackgroundProfiles of microRNA in aqueous humor of normal tension glaucoma patients using RNA sequencing
Seong, H., Cho, H.-K., Kee, C., Song, D. H., Cho, M.-C., & Kang, S. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-98278-0 · Cited by 32
miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery
Rashid, G., Khan, N. A., Elsori, D. H., Youness, R. A., Hassan, H., Siwan, D., Seth, N., Kamal, M. A., Rizvi, S., Babker, A. M. A., et al. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07379-4 · Cited by 32
Endocrine pancreatic development: impact of obesity and diet
O’Dowd, J. F., & Stocker, C. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00170 · Cited by 32
“…miR-375 (Poy et al., 2004). miR-375 is regulated by several transcription factors involved in pancreatic development and function, including HNF6, INSM1, NGN3, NEUROD1, and PDX-1 (Keller et al., 2007), with knockout studies showing that miR-375 is key to pancreatic development (Poy et al., 2009).”
BackgroundChen, X. Y., Li, G. M., Dong, Q., & Peng, H. (2015) · Genetics and Molecular Research · doi:10.4238/2015.november.30.24 · Cited by 31
“However, insulin biosynthesis is an important factor for glucose-induced insulin response under diabetic conditions, characterized by a lack of adaptation of insulin biosynthesis rates to the increased insulin demand (Wente et al., 2006; Reitman, 2013).”
BackgroundQiu, Y., Xu, J., Yang, L., Zhao, G., Ding, J. X., Chen, Q., Zhang, N., Yang, R., Wang, J., Li, S., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112507 · Cited by 30
AMPA Receptors Regulate Exocytosis and Insulin Release in Pancreatic β Cells
Wu, Z., Zhu, L., Zou, N., Bombek, L. K., Shao, C., Wang, N., Wang, X., Liang, L., Xia, J., Rupnik, M. S., et al. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01373.x · Cited by 30
Knudsen, L. A., Petersen, N., Schwartz, T. W., & Egerod, K. L. (2015) · Endocrinology · doi:10.1210/en.2015-1088 · Cited by 28
“The miR-375 knockout mice displayed more -cells with corresponding changes inplasma levelsof glucagonandadecreased -cell mass, resulting in an impaired glucose tolerance (17).”
BackgroundMicroRNA links obesity and impaired glucose metabolism
Ono, K. (2011) · Cell Research · doi:10.1038/cr.2011.78 · Cited by 29
miR-375 induces human decidua basalis-derived stromal cells to become insulin-producing cells
Shaer, A., Azarpira, N., Vahdati, A., Karimi, M., & Shariati, M. (2014) · Cellular and Molecular Biology Letters · doi:10.2478/s11658-014-0207-3 · Cited by 27
Larsen, L., Rosenstierne, M. W., Gaarn, L. W., Bagge, A., Pedersen, L., Dahmcke, C. M., Nielsen, J. H., & Dalgaard, L. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025997 · Cited by 36
MicroRNAs in heart failure: Non-coding regulators of metabolic function
Zhang, X., & Schulze, P. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.009 · Cited by 31
Brazil nut intake increases circulating miR-454-3p and miR-584-5p in obese women
Reis, B. Z., Duarte, G. B. S., Vargas-Méndez, E., Ferreira, L. R. P., Barbosa, F., Cercato, C., Rogero, M. M., & Cozzolino, S. M. F. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.05.004 · Cited by 30
An ‘alpha-beta’ of pancreatic islet microribonucleotides
Dalgaard, L. T., & Eliasson, L. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.01.009 · Cited by 29
MicroRNAs in type 2 diabetes mellitus: potential role of physical exercise
Caria, A. C. I., Sousa, R. A. L. D., Roever, L., Fernandes, T. M., de Oliveira, E. M., Aras, R., & Souza, B. S. D. F. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2301029 · Cited by 27
“Evidence shows that miR-375 regulates the process of insulin secretion [47] and glucose homeostasis [48].”
BackgroundSegregation of neuronal and neuroendocrine differentiation in the sympathoadrenal lineage
Huber, K. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1947-0 · Cited by 29
Brown, L. J., Longacre, M. J., Hasan, N. M., Kendrick, M. A., Stoker, S. W., & MacDonald, M. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040394 · Cited by 27
Zhang, C., Caldwell, T. A., Mirbolooki, M., Duong, D., Park, E. J., Chi, N., & Chessler, S. D. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00318.2015 · Cited by 28
Analysis of miRNAs and their target genes associated with lipid metabolism in duck liver
He, J., Wang, W., Lu, L., Tian, Y., Niu, D., Ren, J., Dong, L., Sun, S., Zhao, Y., Chen, L., et al. (2016) · Scientific Reports · doi:10.1038/srep27418 · Cited by 27
Berry, C., Lal, M., & Binukumar, B. K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00210 · Cited by 41
“Leptin-deficient ob/ob mice—the mouse model for obesity-related diabetes—with miR-375 knocked out also experience a reduction in β cell mass that leads to diabetes (72).”
BackgroundMicroRNAs: markers of β-cell stress and autoimmunity
Dotta, F., Ventriglia, G., Snowhite, I. V., & Pugliese, A. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000420 · Cited by 36
MicroRNAs in Cardiovascular Health: From Order to Disorder
Karunakaran, D., & Rayner, K. J. (2013) · Endocrinology · doi:10.1210/en.2013-1299 · Cited by 26
MicroRNA miR-7 Regulates Secretion of Insulin-Like Peptides
Agbu, P., Cassidy, J. J., Braverman, J., Jacobson, A., & Carthew, R. W. (2019) · Endocrinology · doi:10.1210/endocr/bqz040 · Cited by 27
Molecular Pathways Underlying the Pathogenesis of Pancreatic α-Cell Dysfunction
Kawamori, D., Welters, H. J., & Kulkarni, R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_18 · Cited by 28
Differential expression of circulating microRNAs in diabetic and healthy lean cats
Fleischhacker, S. N., Bauersachs, S., Wehner, A., Hartmann, K., & Weber, K. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2013.03.027 · Cited by 28
“MiR-375 is abundant in pancreatic islets and suppresses glucose-induced insulin secretion when overexpressed (Pandey et al., 2009; Poy et al., 2009).”
BackgroundZhang, Q., Xiao, X., Li, M., Li, W., Yu, M., Zhang, H., Ping, F., Wang, Z., Zheng, J., & Xiang, H. (2014) · Journal of Diabetes Research · doi:10.1155/2014/862473 · Cited by 27
Papageorgiou, I. S., Freytsis, M., & Court, M. H. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.014 · Cited by 26
Noncoding RNAs Carried by Extracellular Vesicles in Endocrine Diseases
Pomatto, M. A. C., Gai, C., Deregibus, M. C., Tetta, C., & Camussi, G. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4302096 · Cited by 27
“Many miRNAs contribute to the adaptive features of beta cells to increase requirements of insulin such as miR-132 [137, 138], miR-184 [139], miR-338-3p [140], and miR-375 [141, 142].”
BackgroundPancreas-specific Gsα deficiency has divergent effects on pancreatic α- and β-cell proliferation
Xie, T., Chen, M., & Weinstein, L. S. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0030 · Cited by 27
“miR-375 null mice develop hyperglycemia with decreased β cell mass and increased α cell mass, similar to PGsKO mice, while overexpression of miR-375 in β cells leads to a β cell defect with diabetes (Poy et al. 2009).”
BackgroundResultNoncoding RNAs in β cell biology
Singer, R. A., Arnes, L., & Sussel, L. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000141 · Cited by 38
Luo, M., Wang, G., Xu, C., Zeng, M., Fang, L., Wu, J., & Wan, Q. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117092 · Cited by 25
Yoshimatsu, G., Takita, M., Kanak, M. A., Haque, W. Z., Chang, C., Saravanan, P. B., Lawrence, M. C., Levy, M. F., & Naziruddin, B. (2016) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.377 · Cited by 25
Metadata
- Authors
- Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- Churchill Hospital (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-07
- Volume
- 106
- Issue
- 14
- Pages
- 5813-5818
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2656556
- OpenAlex
- W2073803015
- Cited by
- 740
- References
- 36
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 35 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 47 · 2017: 58 · 2016: 59 · 2015: 67 · 2014: 72 · 2013: 60 · 2012: 53
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114001, 3100A0)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- miR-375, microRNA, alpha cells, pancreatic beta cells, beta-cell mass, glucose homeostasis, hyperglycemia, glucagon, gluconeogenesis, hepatic glucose production, beta-cell proliferation, islet development, obesity, insulin resistance, diabetes mellitus, cell proliferation
- MeSH terms
- Animals, Blood Glucose, Homeostasis, Insulin, Islets of Langerhans, Mice, Obese, Mice, Knockout, MicroRNAs, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.